ArticleClinical and translational science2023

A leucine-rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls.

Maurits F J M Vissers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.